Amgen slapped with Tavneos suspension in U.K. (AMGN:NASDAQ)
· seekingalpha.com
Amgen (AMGN) and CSL Limited (CSLLY) are slapped with the U.K. suspension of their rare-disorder therapy Tavneos (Avacopan Vifor) over data concerns. Read more here.
The U.K. drug regulator, the Medicines and Healthcare Products Regulatory Agency, has suspended the use of Amgen’s (AMGN) rare-disorder therapy Avacopan Vifor...